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Impaired mucociliary clearance (MCC) is a hallmark of acquired chronic airway diseases
like chronic bronchitis associated with chronic obstructive pulmonary disease (COPD)
and asthma. This manifests as microbial colonization of the lung consequently leading to
recurrent respiratory infections. People living with HIV demonstrate increased incidence
of these chronic airway diseases. Bacterial pneumonia continues to be an important
comorbidity in people living with HIV even though anti-retroviral therapy has succeeded
in restoring CD4+ cell counts. People living with HIV demonstrate increased microbial
colonization of the lower airways. The microbial flora is similar to that observed in
diseases like cystic fibrosis and COPD suggesting that mucociliary dysfunction could
be a contributing factor to the increased incidence of chronic airway diseases in people
living with HIV. The three principal components of the MCC apparatus are, a mucus layer,
ciliary beating, and a periciliary airway surface liquid (ASL) layer that facilitates ciliary
beating. Cystic fibrosis transmembrane conductance regulator (CFTR) plays a pivotal
role in regulating the periciliary ASL. HIV proteins can suppress all the components of the
MCC apparatus by increasing mucus secretion and suppressing CFTR function. This
can decrease ASL height leading to suppressed ciliary beating. The effects of HIV on
MCC are exacerbated when combined with other aggravating factors like smoking or
inhaled substance abuse, which by themselves can suppress one or more components
of the MCC system. This review discusses the pathophysiological mechanisms that lead
to MCC suppression in people living with HIV who also smoke tobacco or abuse illicit
drugs.
Keywords: HIV, tobacco smoke, cocaine, mucociliary clearance, marijuana abuse, cystic fibrosis transmembrane
conductance regulator, ciliary beat frequency
Introduction
With the introduction of combination antiretroviral therapy (cART) dramatic declines in
morbidity and mortality from HIV/AIDS have been seen (Palella et al., 1998). HIV has
become a treatable but chronic disease. People living with HIV live the lifespan equivalent
to that of normal people. However, the incidence of respiratory diseases continues to plague
the HIV-infected population. While a reconstituted immune response in these patients has
decreased the incidence of opportunistic infections like Pneumocystis and bacterial pneumonia,
HIV-infected individuals are still six times more likely to contract pneumonia compared to
non-infected age matched controls (Sogaard et al., 2008). People living with HIV also present
with increased incidence of chronic airway diseases like chronic bronchitis associated with COPD
and asthma characteristically attributed to mucociliary dysfunction. The pathophysiology of these
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lung diseases in the context of HIV infections has still not
been clearly understood. Recent studies show that the lower
respiratory tract is a microbial reservoir in HIV-infected
individuals rather than being a sterile environment as observed
in healthy non-infected subjects and this may contribute to
recurrent pneumonia and COPD in HIV-infected patients
(Huang et al., 2011; Iwai et al., 2012). Moreover, the lung
microbiome in People living with HIV is similar to that observed
in COPD and cystic fibrosis (Huang and Lynch, 2011).
Impaired MCC, is primarily responsible for microbial
colonization of airways in chronic airway diseases like COPD
and cystic fibrosis (Sethi, 2000; Livraghi and Randell, 2007).
MCC is a primary innate defense mechanism of the airways
and protects the host from airborne pathogens, pollutants, and
allergens (Wanner et al., 1996). Optimal MCC requires mucus,
cilia, and a thin layer of ASL to facilitate ciliary beating. CFTR
plays a pivotal role in maintaining ASL depth for optimal MCC
by providing the necessary osmotic gradient through its ability
to secrete Cl− and enhancing paracellular permeability for fluid
transport (Unwalla et al., 2015). Dysregulation of any component
of the MCC system can attenuate MCC promoting microbial
colonization. This results in chronic inflammation, progressive
obstructive lung disease and recurrent lung infections.
People living with HIV demonstrate impaired nasal
MCC (Kellerman, 2002; Robinson and Bye, 2002). Since
the physiological mechanisms regulating nasal MCC are similar
to tracheobronchial MCC it is possible that HIV suppresses
this as well. HIV-infected individuals also abuse street drugs or
smoke tobacco. Cigarette smoking or smoked substance abuse
can exacerbate pulmonary disorders associated with HIV. We
have demonstrated that TGF-β signaling, enhanced by cigarette
smoke and in chronic airway diseases downregulates CFTR
mRNA and function (Snodgrass et al., 2013; Unwalla et al.,
2015) promoting mucociliary dysfunction and by consequence,
microbial colonization. Smoked substance abuse involving
marijuana and cocaine also act on the mucus and ciliary
component of the MCC system. In this concise review we
focus on the pathophysiological mechanisms by which HIV can
by itself, or in combination with cigarette smoke or smoked
substance abuse suppresses MCC.
Mucociliary Dysfunction of the Airways
With inhalation of several thousand liters of air per day,
human airway surfaces are constantly exposed to diverse
environmental particles, allergens, and pathogens (Wanner
et al., 1996). These agents are potent stimuli for airway
inflammation and infections, if they are not removed efficiently
from the lungs (Fujii et al., 2001; Gibson et al., 2003).
Therefore, MCC has long been recognized as a primary
innate defense mechanism of mammalian airways (barrier)
that works in concert with a chemical shield of antimicrobial
substances including lactoperoxidase, lysozyme, and lactoferrin,
to protect the host from the noxious effects of airborne
pathogens, pollutants, and allergens (Wanner et al., 1996; Ganz,
2002). The mucociliary apparatus consists of three functional
compartments, that is, the cilia, a protective mucus layer, and an
ASL layer in between the mucus and the ciliated cells to optimize
ciliary beating. These mechanisms work in concert to remove
inhaled particles from the lung.
Impaired MCC is directly responsible for productive cough,
respiratory infection, and airflow obstruction observed in chronic
airway diseases like cystic fibrosis and COPD associated with
chronic bronchitis. Mucus transport is a function of ASL, ASL
depth, and ciliary beating. Abnormalities in any compartment
of the mucociliary system can compromise mucus clearance and
cause chronic airway disease. Inability to clear mucus or excessive
mucus secretion leads to microbial entrapment and promotes
chronic infection (Gibson et al., 2003).
Ciliary beat frequency (CBF) can directly regulate MCC and
this is evident in diseases like primary ciliary dyskinesia where
attenuated ciliary beating leads to cough, infection, and airway
obstruction (Afzelius, 1976, 1995). Ciliated cells are terminally
differentiated columnar cells and their primary function in the
epithelium is to propel the mucus toward the oral cavity by
coordinated ciliary beating where it can either be expectorated
or swallowed. These cilia are directly attached to the cell surface
by the basal body. The baseline CBF in the upper airway is
anywhere between 12 and 15Hz (Fahy and Dickey, 2010). Based
on external stimuli, the CBF can be increased or decreased by
a number of signaling mechanisms (Salathe, 2007). While the
precise mechanism by which CBF is regulated remains unknown
a number of reports have demonstrated that phosphorylation of
the dynein light chain by cAMP dependent Protein Kinase A
(PKA) leads to increases in CBF (Salathe, 2007). Pharmacological
drugs that lead to activation of adenylate cyclases or inhibit
phosphodiesterases increase cAMP and lead to activation of
PKA and consequently increase CBF (Lafortuna and Fazio, 1984;
Wanner, 1985; Devalia et al., 1992; Milara et al., 2012; Unwalla
et al., 2015). It has been suggested that changes in intracellular
calcium [Ca]i also increases CBF possibly by soluble adenylate
cyclase mediated activation of PKA (Schmid et al., 2007).
Ciliary beating is also affected by periciliary ASL depth that
allows cilia to beat efficiently and is crucial for mediating MCC
rates (Boucher, 2002). Under normal conditions, the height of
ASL is tightly regulated (Boucher, 2003). If the ASL depth is
too high, the cilia cannot efficiently propel mucus. Conversely,
unregulated ASL absorption (as seen in cystic fibrosis) results
in ASL height reduction, impairing effective ciliary beating
and leading to mucus impaction. Studies show that ASL
autoregulation is associated with CFTR mediated inhibition of
Na+ absorption and activation of Cl− secretion (Boucher, 2003).
Water follows through the transcellular/paracellular pathway
maintaining ASL height leading to efficient MCC (Quinton,
1990; Tarran et al., 2001). While bronchial epithelial cells express
aquaporins, deletion mutants of aquaporins demonstrate regular
ASL depth pointing to a paracellular component for fluid
transport (Verkman, 2007). It is now confirmed by a number of
reports, including ours that CFTR also regulates the paracellular
permeability of bronchial epithelium (Divac et al., 2004; Nilsson
et al., 2010; Unwalla et al., 2015), placing CFTR at a critical
juncture in ASL depth regulation where it not the necessary
osmotic gradient but also paracellular permeability and thus fluid
transport. In normal conditions, apical nucleotides (ATP and its
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metabolites) are important for hydrating airway surfaces (e.g.,
Tarran et al., 2006). ATP binds to purinergic G-protein coupled
receptors leading to activation of Ca2+ dependent Cl− channels
and also CFTR. In chronic airway diseases like cystic fibrosis and
COPD, CFTR function is either attenuated or absent. This leads
to a significant decrease in epithelial Cl− secretion, excessive
Na+ absorption (Matsui et al., 1998) and a decreased paracellular
permeability (Divac et al., 2004; Nilsson et al., 2010) an effect
mimicked in COPD and chronic bronchitis (Divac et al., 2004;
Kreindler et al., 2005; Cantin et al., 2006; Savitski et al., 2009)
although not to the same extent. However, the system fully fails
with additional insults (such as inflammation, which is more
evident during disease exacerbations) resulting in reduced ASL
depth mimicking cystic fibrosis.
Both, ASL depth maintenance (by CFTR function) and CBF
activation rely on the common adenylate cyclase/cAMP/PKA
pathway for activation making this pathway critical in
maintenance of optimal MCC. HIV infection, environmental
stimuli/pollutants like cigarette smoke and smoked substance
abuse like crack cocaine, marijuana, methamphetamine can
affect one or more components of the MCC system facilitating
microbial colonization leading to recurrent lung infections and
chronic airway diseases.
HIV Infection
HIV-infected individuals demonstrate all phenotypes of
obstructive lung disease including small airways abnormalities,
bronchiolitis, increases in airway obstruction, air-trapping,
chronic bronchitis, deficits in DLCO (Diffusing capacity of the
lung for carbon monoxide), and anatomic and radiographic
emphysema (Wallace et al., 1997; Diaz et al., 2000, 2003). HIV
is an independent risk factor for COPD when compensated
for smoking (Diaz et al., 2000). HIV-infected subjects are
still six times more predisposed to contracting bacterial
pneumonia compared to non-infected age matched controls in
the post-cART era (Sogaard et al., 2008). Mortality, following
an episode of bacterial pneumonia was also four times higher
in HIV infected subjects compared to non-infected controls
(Hirschtick et al., 1995). Indeed, around 10% of the causes of
severe morbidity and 5% of the causes of death are related to
pneumonia in industrialized countries (Bonnet et al., 2007;
Hessamfar-Bonarek et al., 2010).
This could be due to attenuatedMCC that promotes microbial
colonization of the airways characteristically seen in chronic
airway diseases with impaired MCC. HIV-infected individuals
demonstrate abnormalities in the MCC apparatus (Kellerman,
2002; Robinson and Bye, 2002). While these studies have mainly
dealt with nasal MCC, nasal Cl− eﬄux, and CBF is often
measured as a barometer of overall airway MCC health (Rutland
et al., 1982; Cantin et al., 2006; Zhang et al., 2014). Moreover,
there is an increased incidence of bronchiectasis, which is
characterized by impaired MCC and recurrent infections, in
People living with HIV (Holmes et al., 1992; Sheikh et al., 1997).
Infected alveolar macrophages or other immune cells recruited
by persistent inflammation (due to cigarette smoke, substance
abuse, recurrent pneumonia, or other chronic airway diseases)
can serve as reservoirs of HIV infection in the airway. While
cART can control de novo infection and replication, viral proteins
can still be expressed and secreted by these cells. Moreover,
reports have convincingly shown that active HIV replication
persists in infected individuals despite suppressive cART (Buzón
et al., 2010; Hatano et al., 2013). Specifically, Tat expression is
not suppressed by anti-retrovirals (Wu and Marsh, 2001, 2003;
Kelly et al., 2008; Ensoli et al., 2010). Thus, infected immune cells
can serve as a source of HIV proteins in the airway. Recurrent
lung infections and other chronic inflammation associated with
cigarette smoke can lead to recruitment of infected immune cells.
While most clinical studies have reported undetectable levels of
HIV in patients on cART, these studies involve rigorous follow-
up by research coordinators to minimize the incidence of missed
doses. Studies have shown that non-adherance rates vary widely
from 33 to 75% (Knobel et al., 2009; Murphy et al., 2012).
Missed doses or episodes of inflammation can lead to bursts of
HIV replication and increase viral proteins in the lung. HIV
Tat protein has a protein transduction domain that allows its
secretion by infected cells and uptake by bystander cells where it
mediates pleotropic effects (Frankel and Pabo, 1988; Ensoli et al.,
1990, 1993; Chang et al., 1997). We have already demonstrated
that TGF-β1 signaling increased in chronic airway diseases and
in smokers can suppress CFTR function (Unwalla et al., 2015).
HIV Tat has been shown to induce TGF-β1 expression in a
number of cell types (Gibellini et al., 1994; Thatikunta et al., 1997;
Reinhold et al., 1999) possibly by binding to a Tat responsive
element in the TGF-β1 promoter (Cupp et al., 1993; Thatikunta
et al., 1997). Recombinant HIV Tat increases TGF-β1 mRNA
in primary human bronchial epithelial cells and this leads to a
concomitant decrease in CFTR mRNA (Figure 1A and Unwalla,
2015).
Although mucus is an essential component of MCC, excessive
mucus production can contribute to airway obstruction and
pathogenesis of COPD, airway inflammation, asthma, and
chronic bronchitis. HIV env protein gp120 has been shown
to increase mucus production in primary bronchial epithelial
cells. Gundavarapu et al. have demonstrated that gp120 derived
from X4 tropic viral strains but not R5 tropic viral strains
increase mucus production in differentiated primary human
bronchial epithelial cells (Gundavarapu et al., 2013). Inhibitors of
CXCR4 and α7-nAChR-GABAARα2 blocked mucus production
in differentiated primary human bronchial epithelial cells in vitro
suggesting that HIV gp120 signals by binding to CXCR4
receptor and this pathway also involves α7-nAChR-GABAARα2.
A number of reports have suggested that binding of HIV gp120
to its co-receptors results in signaling cascades that facilitate viral
entry and replication (Stantchev and Broder, 2001; Freedman
et al., 2003; Yi et al., 2004). CXCR4 is a G-protein coupled
receptor that associates with Gαi which inhibits adenylate cyclase
activation. Since both CFTR activation and ciliary beating
depends on the Adenylate cyclase/cAMP/PKA pathway, gp120
can potentially suppress CFTR activation as well. Thus, HIV
proteins Tat and gp120 can by itself suppressMCC in the airways.
Approximately 80% of HIV-infected individuals also smoke
tobacco or abuse other street drugs (NSDUH, 2010 and Figure 1).
Mucociliary dysfunction can be exacerbated in People living with
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FIGURE 1 | (A) HIV Tat induces expression of TGF-β1 mRNA with a concomitant decrease in CFTR mRNA levels. NHBE ALI cultures re-differentiated at the air liquid
interface were treated with recombinant Clade B Tat (10 nM: *p < 0.05) apically and basolaterally. Total RNA was isolated and TGF-β1 and CFTR mRNA levels were
quantitated by qRT-PCR. HIV Tat induces almost a 1.7-fold increase in TGF-β1 mRNA expression. This translates to a significant decrease in CFTR mRNA levels. Data
are mean ± SE of three experiments from three different lungs. (B) Nationwide trends in Cigarette smoking and drug abuse in general population compared with
people living with HIV. While the trend in addiction is similar between the two, the proportion of people living with HIV who smoke cigarettes or abuse street drugs is
significantly than that observed in the general population. Cigarette smoking is the most prevalent addiction [62.5% smokers (Benard et al., 2007; Lifson et al., 2010;
Lifson and Lando, 2012) compared to 17.8% nationwide], followed by Marijuana [29% (Woolridge et al., 2005) compared to 7.5% nationwide], Cocaine [22.5%
(Hinkin et al., 2004) compared to 0.6% nationwide] and methamphetamine [11% (Mitchell et al., 2006) compared to 0.2% nationwide]. The data for substance abuse
in the general population is obtained from http://www.drugabuse.gov/national-survey-drug-use-health.
HIV who smoke tobacco or street drugs since smoking and drug
abuse are independent risk factors for mucociliary dysfunction
often presenting with airway diseases characteristic of impaired
mucociliary function like chronic bronchitis associated with
COPD, asthma, and recurrent lung infections.
Smoked Substance Abuse
Despite the declining prevalence of smoking in the United
States (http://www.cdc.gov/tobacco/data_statistics/tables/trends/
cig_smoking/index.htm), a significant proportion of HIV-
infected individuals are cigarette smokers or smoked
substance abusers (Figure 1B). Indeed the proportion
of people who smoke tobacco or other illicit drugs is
significantly higher in people living with HIV compared to
trends observed in overall population (http://www.drugabuse.
gov/national-survey-drug-use-health). Almost 60% of People
living with HIV are also smokers (Benard et al., 2007; Lifson
et al., 2010; Lifson and Lando, 2012). Cigarette smoking is the
most prevalent addiction followed by Marijuana, Cocaine and
methamphetamine. Cigarette smoking and smoking street drugs
result in the airway exposed to the highest concentration of
these drugs. Use of methamphetamine by smoking is the fastest
growing mode of administration, which increases concerns
about potential pulmonary and other medical complications.
Currently, no peer-reviewed papers exist that have investigated
the effects of methamphetamine abuse on the mucociliary
system. Cigarette smoke by itself is a potent risk factor for
chronic bronchitis associated with COPD. Chronic bronchitis,
even though a clinical diagnosis, is characterized by mucus
hypersecretion and reduced MCC. Cigarette smoke can suppress
MCC by directly interfering with all three components of the
MCC apparatus namely, increasing mucus secretion (Mebratu
et al., 2011), reducing CBF as well as shortening cilia length
(Cohen et al., 2009; Leopold et al., 2009) and suppressing ASL
depth by inhibiting CFTR either directly, by sequestering surface
CFTR molecules in aggregosomes and or by suppressing CFTR
biogenesis via TGF-β signaling (Cohen et al., 2009; Clunes
et al., 2012; Unwalla et al., 2015). While Cigarette smoke only
activates available TGF-β1 to suppress CFTR biogenesis, it
does not increase in TGF-β1 levels in airway epithelial cells
(Unwalla et al., 2015). HIV Tat on the other hand also increases
TGF-β1 mRNA levels and/or signaling. Thus, in HIV infected
patients there is increased availability of TGF-β1. Hence in
HIV infected smokers CFTR suppression can be exacerbated
due to an additive effect of HIV Tat and cigarette smoke. This
can decrease the periciliary fluid leading to attenuated ciliary
beating. Moreover, HIV gp120 can also stimulates mucus
hypersecretion (Gundavarapu et al., 2013). Hence it is expected
that a combination of HIV and smoking can lead to a profound
suppressive effect on MCC.
Likewise Marijuana smoking can also synergize with HIV
infection to have an additive effect on MCC suppression. While
short-termmarijuana use has not been implicated in any decrease
in pulmonary function, when compared to tobacco smoke,
long term cannabis smoking results in symptoms similar to
that observed in smokers with coughing, chronic bronchitis
and increased mucus production. While there are no reports
of any direct or indirect action of marijuana smoking on
CFTR function, marijuana smoking has been shown to decrease
ciliated cells, increase mucus-producing cells and lead to cellular
disorganization with squamous metaplasia (Gong et al., 1987). In
HIV-infected marijuana smokers, a combination of factors like
CFTR mRNA suppression (by Tat), increased mucus production
(due to gp120 and effects of marijuana) and decreased number of
ciliated cells (by marijuana) can lead to MCC suppression greater
than that observed for marijuana or HIV alone.
Cocaine abuse either by way of snorting crystalline cocaine
or smoking crack cocaine results in the airway exposed to the
highest concentration of this drug. Asthma and COPD are
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common among cocaine users (Rubin and Neugarten, 1990;
Leece et al., 2013). Moreover, a single exposure to cocaine can
lead to persistence of the drug in the airway hours after smoking
(Byck and Van Dyke, 1977). Cocaine has been shown to decrease
CBF with higher doses causing irreversible ciliostasis (Barton and
Gray, 1979; Robson et al., 1992; Ingels et al., 1994). Apart from
its effects on ciliary beating, Cocaine has also been shown to
affect the airway mucosa in several other ways. Cocaine, at high
concentrations has been shown to suppress basal short circuit
current (generally a function of Cl− eﬄux or Na+ absorption
from themucosal side of the epithelium). Cocaine was also shown
to suppress Cl− eﬄux in response to CFTR potentiators like β2-
agonsits (Farley et al., 1991). In HIV-infected individuals that
also abuse crack cocaine, the combined effects of Tat-mediated
suppression of CFTR (and by extension ASL depth) and cocaine
mediated ciliary dyskinesia or ciliostasis can lead to a synergistic
effect on MCC suppression.
Restoration of MCC in People Living with
HIV Who also Abuse Street Drugs
Two major components of the MCC apparatus namely, ASL
depth maintenance (as a consequence of CFTR function)
and CBF depend on the adenylate cyclase/cAMP/PKA
pathway. Hence therapeutics that potentiate this pathway
can be used to restore MCC in HIV infected individuals
and/or smoked substance abusers (Figure 2). β2-adrenergic
receptors are spatially and functionally coupled to the adenylate
cyclase/cAMP/PKA pathway and CFTR (Naren et al., 2003). The
use of β2-agonists as an alternative mechanism to restore MCC
along with its prescribed use as bronchodilators in chronic airway
diseases like asthma and COPD is attractive in that a time-tested
drug can serve a dual purpose to ameliorate two symptoms
associated with these diseases. Apart from their known ability to
serve as bronchodilators, we and others have shown that they can
potentially improve MCC in three distinct ways by increasing
CBF (van As, 1974; Wanner et al., 1996; Unwalla et al., 2015),
activating CFTR (Gilljam et al., 1987; Unwalla et al., 2015), and
consequently, increasing paracellular permeability (Unwalla
et al., 2012). Alternately, another drug Roflumilast, a Cyclic
nucleotide phosphodiesterase (PDE) inhibitor can strongly
increase Cl− eﬄux by CFTR, enhance CBF, and MCC in COPD
and in response to cigarette smoke (Baumlin et al., 2014; Lambert
et al., 2014; Tyrrell et al., 2015). The cAMP-selective PDE4 family
is a major isoform found in respiratory epithelia and in resident
immune cells of the lung. Inhibition of PDE4 would increase
cAMP available for PKA mediated activation of CFTR and
CBF. A synergistic effect is observed on MCC restoration when
Roflumilast is used in combination with β2-agonists (Baumlin
et al., 2014). This could be because β2-agonsists enhance cAMP
production by Gαs mediated activation of adenylate cyclase while
PDE inhibition by Roflumilast decreases the turnover of cAMP.
Alternately CFTR potentiators like Ivacaftor can also been used
to restore CFTR function and enhance MCC (Sloane et al., 2012).
FIGURE 2 | Schematic model of HIV and substance abuse induced Mucociliary dysfunction. HIV Tat and Cigarette smoke can inhibit CFTR biogenesis and
function. HIV Tat increases TGF-β1 mRNA levels with a corresponding decrease in CFTR mRNA. Cigarette smoke can suppress CFTR biogenesis by TGF-β1 signaling
or directly inhibit CFTR function by trapping surface CFTR in aggregosomes. Cigarette smoke, marijuana and cocaine can also inhibit the Ciliary component of MCC
by decreasing CBF or ciliostasis (by cocaine). Marijuana smoking can lead to a loss of ciliated cells in the airway epithelium. The effects of these drugs on the ciliary
component can synergize with the effects of HIV Tat mediated suppression of CFTR leading to a pronounced suppression of MCC. A combination of HIV gp120,
Cigarette smoke and/or Marijuana can also promote mucus hypersecretion in the milieu where CFTR function is already attenuated by Tat and cigarette smoke leading
to Dysregulation of all the principal components of the MCC system. Dysregulation of one or more components of the MCC system will lead to mucus impaction and
microbial colonization. Pharmaceutical drugs that increase intracellular cAMP by either activating cyclase or inhibiting phosphodiesterase when used in combination
with CFTR potentiators like Ivacaftor can restore one or more components of the MCC and repair the mucociliary dysfunction.
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Conclusions
Normal mucociliary function fails with dysfunction of any
one of the major components of the MCC apparatus namely
mucus production, ciliary beating, and ASL depth maintenance
fail. Suppression of MCC leads to an inefficient clearance
of pollutants, pathogens, and allergens. This leads to chronic
inflammation and microbial colonization which manifests
as chronic airway diseases like asthma, chronic bronchitis
associated with COPD, and recurrent lung infections pervasive
in HIV infected individuals and/or smoked substance abusers.
Smoked substance abuse can suppress MCC independently
and an underlying HIV infection can have an additive effect
as each of these can suppress one or more components of
MCC system. Under these conditions, therapeutics that can
restore CFTR function or CBF can restore MCC and prevent
microbial colonization consequently decreasing the incidence of
pneumonia in People living with HIV.
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